Results 41 to 50 of about 22,410 (194)
CLINICAL VARIANTS AND ASPECTS OF SURGICAL TREATMENT OF PATIENTS WITH HYPERPARATHYROIDISM
Introduction. In clinical practice, it is important to apply a differentiated approach to selecting the treatment strategy for patients with hyperparathyroidism, depending on clinical manifestations and laboratory changes. Aim.
Tamara S. Vatseba +4 more
doaj +1 more source
Brown Tumors of the Jaws: A Retrospective Study
Objectives: (1) Describe the clinical spectrum, imaging features, management, and outcome of brown tumors (BT) of the jaws. (2) Determine via a literature review the facts and controversies around the characteristics and management of this lesion ...
Maya Fedhila +8 more
doaj +1 more source
Abstract An 81‐year‐old man with a history of high‐grade urothelial carcinoma of the bladder and ureter on treatment with atezolizumab and tiragolumab presented to the emergency department with 5 months of malaise, generalized weakness, and fatigue and 2 weeks of subjective fevers. One month prior to presentation, he received an empiric 9‐day course of
Hadi Roudsari +4 more
wiley +1 more source
A case report of multiple giant cell granulomas related to tertiary hyperparathyroidism
Introduction: Excessive secretion of parathyroid hormone results in hyperparathyroidism which is classified into primary, secondary and tertiary categories.
Parviz Deyhimi +4 more
doaj
Bacterial specificity of the gut microbiome predicts bone density in primary hyperparathyroidism
Primary hyperparathyroidism causes mild-to-severe bone loss, but the reason for this heterogeneity is unclear. We investigated the role of the microbiome in 50 primary hyperparathyroidism patients.
Hamid Y. Dar +8 more
doaj +1 more source
Some cases of primary hyperparathyroidism may not be truly primary in origin
Primary hyperparathyroidism (PHPT) is the third most common endocrine disorder and is traditionally considered to result from intrinsic pathology.
De-ya Kong +10 more
doaj +1 more source
Are the historical 1%–4% thyroid uptake reference values still valid in modern practice? This editorial examines why contemporary Australian and international data suggest otherwise and situates the new reference range reported by Wornes (https://doi.org/10.1002/jmrs.70078) and colleagues within the broader international literature.
Geoffrey Schembri, Jeremy Hoang
wiley +1 more source
Introduction: Primary hyperparathyroidism is an endocrine disorder that causes disturbances in calcium and phosphorus metabolism in the human body.
Laura Loryś +7 more
doaj +1 more source
ABSTRACT Advances in therapy have extended the life expectancy of patients with thalassemia to near that of the general population; complications such as endocrine disorders and osteoporosis remain prevalent. This study aimed to identify endocrine complications, factors associated with endocrine complications, and changes in bone mineral density (BMD ...
Cheng‐Ying Hsu +7 more
wiley +1 more source
Mandibular Osteitis Fibrosa Cystica as First Sign of Vitamin D Deficiency
Introduction. Brown tumors of hyperparathyroidism are locally destructive bone lesions. They are the late clinical consequence of the disease. They can occur in primary, secondary, and rarely tertiary forms.
Nour Mellouli +5 more
doaj +1 more source

